MINERALOCORTICOID RECEPTOR ANTAGONISM IN CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Gillis, Keith [1 ]
Lees, Jennifer [2 ]
Jardine, Alan [2 ]
Traynor, Jamie [1 ]
Mark, Patrick [2 ]
机构：
[1] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP111
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [31] Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease
    Zachariah, Teena
    Radhakrishnan, Jai
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (11): : 1499 - 1512
  • [32] Antagonism in the human mineralocorticoid receptor
    Fagart, J
    Wurtz, JM
    Souque, A
    Hellal-Levy, C
    Moras, D
    Rafestin-Oblin, ME
    EMBO JOURNAL, 1998, 17 (12): : 3317 - 3325
  • [33] Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease
    Provenzano, Michele
    Andreucci, Michele
    Garofalo, Carlo
    Minutolo, Roberto
    Serra, Raffaele
    De Nicola, Luca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (03) : 253 - 262
  • [34] Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Ding, Kaiyue
    Li, Zhuoyu
    Lu, Yingying
    Sun, Lin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 114 - 127
  • [35] Effects of Chronic Kidney Disease on Nanomechanics of the Endothelial Glycocalyx Are Mediated by the Mineralocorticoid Receptor
    Fels, Benedikt
    Beyer, Arne
    Cazana-Perez, Violeta
    Giraldez, Teresa
    Navarro-Gonzalez, Juan F.
    de la Rosa, Diego Alvarez
    Schaefer, Franz
    Bayazit, Aysun K.
    Obrycki, Lukasz
    Ranchin, Bruno
    Holle, Johannes
    Querfeld, Uwe
    Kusche-Vihrog, Kristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [36] Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
    Miki Nagase
    Clinical and Experimental Nephrology, 2010, 14 : 303 - 314
  • [37] Mineralocorticoid receptor antagonists: part of an emerging treatment paradigm for chronic kidney disease
    Epstein, Murray
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (12): : 925 - 927
  • [38] Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
    Akira Nishiyama
    Hypertension Research, 2019, 42 : 293 - 300
  • [39] Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease
    Plicas, Mariana Morais David
    da Silva, Bernardo Marques
    de Almeida, Edgar Avito Fernandes
    NEFROLOGIA, 2025, 45 (03): : 214 - 227
  • [40] Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
    Nagase, Miki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (04) : 303 - 314
12345